chr9-432330-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_203447.4(DOCK8):​c.4785+6C>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.757 in 1,613,316 control chromosomes in the GnomAD database, including 466,623 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.70 ( 38123 hom., cov: 30)
Exomes 𝑓: 0.76 ( 428500 hom. )

Consequence

DOCK8
NM_203447.4 splice_region, intron

Scores

2
Splicing: ADA: 0.00009776
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10O:1

Conservation

PhyloP100: 0.213
Variant links:
Genes affected
DOCK8 (HGNC:19191): (dedicator of cytokinesis 8) This gene encodes a member of the DOCK180 family of guanine nucleotide exchange factors. Guanine nucleotide exchange factors interact with Rho GTPases and are components of intracellular signaling networks. Mutations in this gene result in the autosomal recessive form of the hyper-IgE syndrome. Alternatively spliced transcript variants encoding different isoforms have been described.[provided by RefSeq, Jun 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 9-432330-C-G is Benign according to our data. Variant chr9-432330-C-G is described in ClinVar as [Benign]. Clinvar id is 163176.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-432330-C-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.958 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DOCK8NM_203447.4 linkc.4785+6C>G splice_region_variant, intron_variant Intron 37 of 47 ENST00000432829.7 NP_982272.2 Q8NF50-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DOCK8ENST00000432829.7 linkc.4785+6C>G splice_region_variant, intron_variant Intron 37 of 47 1 NM_203447.4 ENSP00000394888.3 Q8NF50-1

Frequencies

GnomAD3 genomes
AF:
0.696
AC:
105596
AN:
151788
Hom.:
38106
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.487
Gnomad AMI
AF:
0.638
Gnomad AMR
AF:
0.793
Gnomad ASJ
AF:
0.732
Gnomad EAS
AF:
0.981
Gnomad SAS
AF:
0.689
Gnomad FIN
AF:
0.788
Gnomad MID
AF:
0.759
Gnomad NFE
AF:
0.763
Gnomad OTH
AF:
0.711
GnomAD2 exomes
AF:
0.766
AC:
192546
AN:
251346
AF XY:
0.763
show subpopulations
Gnomad AFR exome
AF:
0.481
Gnomad AMR exome
AF:
0.852
Gnomad ASJ exome
AF:
0.712
Gnomad EAS exome
AF:
0.985
Gnomad FIN exome
AF:
0.795
Gnomad NFE exome
AF:
0.766
Gnomad OTH exome
AF:
0.757
GnomAD4 exome
AF:
0.763
AC:
1114842
AN:
1461410
Hom.:
428500
Cov.:
47
AF XY:
0.761
AC XY:
553218
AN XY:
727042
show subpopulations
Gnomad4 AFR exome
AF:
0.476
AC:
15910
AN:
33454
Gnomad4 AMR exome
AF:
0.845
AC:
37799
AN:
44712
Gnomad4 ASJ exome
AF:
0.713
AC:
18623
AN:
26124
Gnomad4 EAS exome
AF:
0.980
AC:
38920
AN:
39696
Gnomad4 SAS exome
AF:
0.689
AC:
59416
AN:
86244
Gnomad4 FIN exome
AF:
0.794
AC:
42390
AN:
53412
Gnomad4 NFE exome
AF:
0.766
AC:
852028
AN:
1111626
Gnomad4 Remaining exome
AF:
0.757
AC:
45717
AN:
60378
Heterozygous variant carriers
0
13051
26102
39152
52203
65254
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
20420
40840
61260
81680
102100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.696
AC:
105662
AN:
151906
Hom.:
38123
Cov.:
30
AF XY:
0.700
AC XY:
51954
AN XY:
74238
show subpopulations
Gnomad4 AFR
AF:
0.487
AC:
0.487186
AN:
0.487186
Gnomad4 AMR
AF:
0.793
AC:
0.7929
AN:
0.7929
Gnomad4 ASJ
AF:
0.732
AC:
0.732143
AN:
0.732143
Gnomad4 EAS
AF:
0.981
AC:
0.98103
AN:
0.98103
Gnomad4 SAS
AF:
0.690
AC:
0.689942
AN:
0.689942
Gnomad4 FIN
AF:
0.788
AC:
0.787732
AN:
0.787732
Gnomad4 NFE
AF:
0.763
AC:
0.762998
AN:
0.762998
Gnomad4 OTH
AF:
0.713
AC:
0.7132
AN:
0.7132
Heterozygous variant carriers
0
1483
2966
4450
5933
7416
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
812
1624
2436
3248
4060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.730
Hom.:
10715
Bravo
AF:
0.690
Asia WGS
AF:
0.823
AC:
2862
AN:
3478
EpiCase
AF:
0.751
EpiControl
AF:
0.763

ClinVar

Significance: Benign
Submissions summary: Benign:10Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

4785+6C>G in intron 37 of DOCK8: This variant is not expected to have clinical s ignificance because it has been identified in 49.3% (2171/4406) of African Ameri can chromosomes from a broad population by the NHLBI Exome Sequencing Project (h ttp://evs.gs.washington.edu/EVS; dbSNP rs7036567). -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 96% of patients studied by a panel of primary immunodeficiencies. Number of patients: 92. Only high quality variants are reported. -

not provided Benign:2Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -

Combined immunodeficiency due to DOCK8 deficiency Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
6.6
DANN
Benign
0.49
Mutation Taster
=88/12
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000098
dbscSNV1_RF
Benign
0.042
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs7036567; hg19: chr9-432330; API